Moore Law Firm Mass Tort Update

Please find an overview of the current pending Mass Tort Claims our firm is investigating involving medical and pharmaceutical products. For more information please contact us today.

BENICAR – This blood pressure medication can cause significant intestinal, gastrointestinal, and colonic diseases. Some of the symptoms include chronic and severe diarrhea, malabsorption, dehydration, malnutrition, weight loss, sprue-like enteropathy, villous atrophy, lymphocytic, collagenous and/or microscopic colitis, etc., and can lead to renal failure. There are four medications involved in this mass tort lawsuit: Benicar, Benicar HCT, Azor, and Tribenzor.

TRANS VAGINAL MESH – Defective mesh implanted transvaginally to treat incontinence and/or prolapse.
****CONSUMER ALERT —- A mass tort settlement deadline is pending for many claims. Many claimants who had cases reviewed and turned down now qualify for compensation under the new settlement participation requirements.

BAIR HUGGER – Most hip and knee implant surgeries include a piece of equipment – a Forced Air Warming (FAW) Device. The Bair Hugger, which is a FAW device that has over 90% of the market share, has been shown to disrupt the operating room airflow and contaminate the sterile field. From 1990 to the present, there is a clear connection between the use of the Bair Hugger and the incidence of prosthetic joint infections. In 1998, there were 2 million units used in the US and in 2014, there were 14 million units used in the US.

INVOKA (Invokamet) – An SGLT2 Inhibitor used to lower blood sugar in adults with type 2 diabetes. SGLT2 inhibitors lower a person’s blood sugar by causing the kidneys to remove it through the urine. Several of these medications can cause an increased risk of kidney failure, heart attacks, other cardiovascular issues and ketoacidosis. The brand name medications involved are Invokana (Invokamet) Canagliflozin, Invokamet Canagliflozin and Metformin, Farxiga Dapagliflozin, Xigduo XR Dapagliflozin and Metformin extended-release, Jardiance Empagliflozin, and Glyxambi Empagliflozin and Linagliptin.

MEDTRONIC INFUSION PUMP – Surgically implantable devices meant to deliver medication to an area near a patient’s spinal cord. It is used to treat patients that have been diagnosed with cancer, severe muscle spasms, chronic pain, and other serious disorders. The device can stall due to motor corrosion and fail to deliver the medication. As of April 2015, dozens of Class I recalls have been issued by the FDA.

WRIGHT HIP IMPLANTS – Defective. To qualify for compensation a claimant must have had the hip implant surgically removed and replaced.

MIRENA IUD – An intrauterine birth control device. Under current review criteria the IUD must have migrated and perforated the intestines or some other organ and required surgical removal of the IUD under general anesthesia to qualify for compensation.